Skip to main content

Advertisement

SpringerLink
Log in

Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Gamble LA, Heller T, Davis JL. Hereditary diffuse gastric cancer syndrome and the role of CDH1: a review. JAMA Surg. 2021;156(4):387–92.

    Article  PubMed  Google Scholar 

  2. Carneiro P, Fernandes MS, Figueiredo J, et al. E-cadherin dysfunction in gastric cancer—cellular consequences, clinical applications and open questions. FEBS Lett. 2012;586(18):2981–9.

    Article  CAS  PubMed  Google Scholar 

  3. Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020;21(8):e386–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. David JM, Rajasekaran AK. Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Res. 2012;72(12):2917–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhao H, Hu H, Chen B, et al. Overview on the role of E-Cadherin in gastric cancer: dysregulation and clinical implications. Front Mol Biosci. 2021;8:689139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Martha E. Teke MD, Lauren A. Gamble MD, Sarah G. Samaranayake MS, Benjamin L. Green MD, Areeba Saif MD, Jonathan M. Hernandez MD & Jeremy L. Davis MD

Authors
  1. Martha E. Teke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lauren A. Gamble MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah G. Samaranayake MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benjamin L. Green MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Areeba Saif MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeremy L. Davis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeremy L. Davis MD.

Ethics declarations

Disclosure

The authors declare no potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teke, M.E., Gamble, L.A., Samaranayake, S.G. et al. Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome. Ann Surg Oncol 29, 7955–7957 (2022). https://doi.org/10.1245/s10434-022-12288-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12288-4

Search

Navigation